Accuracy and Interobserver Reliability of Magnetic Resonance Imaging for Placenta Accreta Spectrum Disorders

Abstract

Objective This study aims to define the accuracy, predictive value, and interobserver reliability of magnetic resonance imaging (MRI) in the diagnosis of placenta accreta spectrum (PAS) disorders.

Study Design Two experienced radiologists independently interpreted the MRI studies of patients with possible PAS from two referral centers. Radiologists were blinded to sonographic and clinical information. We calculated diagnostic testing characteristics and kappa statistics of interobserver reliability for MRI findings of PAS.

Results Sixty-eight MRI cases were evaluated. Confirmed PAS and severe PAS were present in 44 (65%) and 20 (29%) cases. For the diagnosis of any PAS, MRI had a sensitivity 66%, specificity 71%, positive predictive value (PPV) 81%, negative predictive value (NPV) 53%, and accuracy 68%. For the diagnosis of severe PAS (percreta), MRI had a sensitivity 85%, specificity 79%, PPV 63%, NPV 93%, and accuracy 81%. The accuracy of individual signs of PAS was lower (44–65%). Interobserver agreement was almost perfect for previa; substantial for myometrial interruptions, PAS, severe PAS, and placental bulging/balling; and moderate to slight for other signs of PAS.

Conclusion Although the interobserver reliability of MRI for a diagnosis of PAS is substantial, the accuracy and predictive value are modest and lower than previously reported.

Keywords

accreta - diagnosis - magnetic resonance imaging - placenta accreta spectrum

Note

These study findings were presented at the Society for Maternal-Fetal Medicine meeting in Las Vegas, Nevada, January 23 to 27, 2017.

Publikationsverlauf

Eingereicht: 28. Juli 2019

Angenommen: 16. Dezember 2019

Artikel online veröffentlicht:
27. Januar 2020

• References

• 1 Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005; 192 (05) 1458-1461
• 2 Mogos MF, Salemi JL, Ashley M, Whiteman VE, Salihu HM. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011. J Matern Fetal Neonatal Med 2016; 29 (07) 1077-1082
• 3 Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand 2011; 90 (10) 1140-1146
• 4 Eller AG, Bennett MA, Sharshiner M. et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011; 117 (2 Pt 1): 331-337
• 5 Shamshirsaz AA, Fox KA, Salmanian B. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212 (02) 218.e1-218.e9
• 6 Bartels HC, Rogers AC, O'Brien D, McVey R, Walsh J, Brennan DJ. Association of Implementing a Multidisciplinary Team Approach in the Management of Morbidly Adherent Placenta With Maternal Morbidity and Mortality. Obstet Gynecol 2018; 132 (05) 1167-1176
• 7 Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet 2018; 140 (03) 274-280
• 8 Placenta accreta spectrum. Obstetric care consensus no. 7. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018; 132: 259-275
• 9 Budorick NE, Figueroa R, Vizcarra M, Shin J. Another look at ultrasound and magnetic resonance imaging for diagnosis of placenta accreta. J Matern Fetal Neonatal Med 2017; 30 (20) 2422-2427
• 10 Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, Sisodia RC, Gervais DA, Lee SI. MRI of placenta accreta, placenta increta, and placenta percreta: pearls and pitfalls. AJR Am J Roentgenol 2017; 208 (01) 214-221
• 11 Jauniaux E, Alfirevic Z, Bhide AG. et al; Royal College of Obstetricians and Gynaecologists. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG 2019; 126 (01) e1-e48
• 12 Collins SL, Alemdar B, van Beekhuizen HJ. et al; International Society for Abnormally Invasive Placenta (IS-AIP). Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the international society for abnormally invasive placenta. Am J Obstet Gynecol 2019; 220 (06) 511-526
• 13 Cal M, Ayres-de-Campos D, Jauniaux E. International survey of practices used in the diagnosis and management of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2018; 140 (03) 307-311
• 14 D'Antonio F, Iacovella C, Palacios-Jaraquemada J, Bruno CH, Manzoli L, Bhide A. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014; 44 (01) 8-16
• 15 Familiari A, Liberati M, Lim P. et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2018; 97 (05) 507-520
• 16 Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver RM. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol 2018; 218 (06) 618.e1-618.e7
• 17 Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005; 37 (05) 360-363
• 18 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (01) 159-174
• 19 Palacios-Jaraquemada JM, Bruno CH, Martín E. MRI in the diagnosis and surgical management of abnormal placentation. Acta Obstet Gynecol Scand 2013; 92 (04) 392-397
• 20 Goergen SK, Posma E, Wrede D. et al. Interobserver agreement and diagnostic performance of individual MRI criteria for diagnosis of placental adhesion disorders. Clin Radiol 2018; 73 (10) 908.e1-908.e9
• 21 Ueno Y, Maeda T, Tanaka U. et al. Evaluation of interobserver variability and diagnostic performance of developed MRI-based radiological scoring system for invasive placenta previa. J Magn Reson Imaging 2016; 44 (03) 573-583
• 22 Valentini AL, Gui B, Ninivaggi V. et al. The morbidly adherent placenta: when and what association of signs can improve MRI diagnosis? Our experience. Diagn Interv Radiol 2017; 23 (03) 180-186
• 23 Chen T, Xu XQ, Shi HB, Yang ZQ, Zhou X, Pan Y. Conventional MRI features for predicting the clinical outcome of patients with invasive placenta. Diagn Interv Radiol 2017; 23 (03) 173-179
• 24 Delli Pizzi A, Tavoletta A, Narciso R. et al. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome. Abdom Radiol (NY) 2019; 44 (05) 1873-1882
• 25 Morel O, Collins SL, Uzan-Augui J. et al; International Society for Abnormally Invasive Placenta (IS-AIP). A proposal for standardized magnetic resonance imaging (MRI) descriptors of abnormally invasive placenta (AIP) - From the International Society for AIP. Diagn Interv Imaging 2019; 100 (06) 319-325